Acer Therapeutics Inc.

Acer Therapeutics Inc.

ACER
Acer Therapeutics Inc.US flagNASDAQ Capital Market
0.66
USD
-0.14
- -

Acer Therapeutics Inc. (ACER) Stock Split History

Learn about Acer Therapeutics Inc.'s most recent 12-for-125 basis stock split on September 21, 2017. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Acer Therapeutics Inc.'s most recent stock split

Split Date: 2017-09-21
Split Ratio: 12:125
Price Before Split: $0.94
Price After Split: $0.09

Developer API

Get ACER split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ACER

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.42 times fewer shares (a 12:125 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Acer Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2017-09-2112:125Yes$0.94$0.09
2015-09-291:8Yes$0.30$0.04
2012-12-171:4Yes$1.40$0.35
2006-06-191:10Yes$3.60$0.36
2004-04-141:50Yes$1.44$0.03

About Acer Therapeutics Inc.

Company overview and industry information

Acer Therapeutics Inc. (ACER) operates in the Biotechnology industry. The recent 12-for-125 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Acer Therapeutics Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.